This study on ADHD medication during pregnancy is the first to examine long-term neurodevelopment after prenatal exposure to stimulants.
This study on ADHD medication during pregnancy is the first to examine long-term neurodevelopment after prenatal exposure to stimulants. CDC PHIL
MedBound Blog

Pregnant Women with ADHD Can Breathe a Sigh of Relief

MBT Desk

Women around the world who have taken medication to treat attention deficit hyperactivity disorder (ADHD) during their pregnancy can now breathe a sigh of relief. There are no differences in rates of neurodevelopmental disorders between children who were exposed and those who were unexposed to stimulant medication in-utero, according to new research conducted by research conducted by the Icahn School of Medicine at Mount Sinai in New York and Aarhus University in Denmark and published February 9 in Molecular Psychiatry.

This study on ADHD medication during pregnancy is the first to examine long-term neurodevelopment after prenatal exposure to stimulants. The researchers Icahn Mount Sinai and the Center for Register Research at Aarhus University examined more than 1 million children born between 1998 and 2015 in Denmark and followed through 2018. They identified almost 900 children whose mothers either continued treatment with ADHD medication throughout pregnancy or started on ADHD medication during pregnancy, and 1270 children whose mothers stopped taking ADHD medication before pregnancy.  

Researchers from Icahn Mount Sinai and the Center for Register Research found at Aarhus University found no changes in the likelihood of developing a neurodevelopmental disorder among children who were exposed to ADHD medication during their mothers’ pregnancy. 

The Center for Disease Control and Prevention estimates that 4% of women aged 15-44 years are using ADHD medication in the U.S., making these medications among most prescribed medications during pregnancy. Currently, there are no clinical guidelines in relation to pregnancy and ADHD medication, which poses a problem for psychiatrists, general practitioners, midwives, nurses and other healthcare professionals who are tasked with advising women before conception or during pregnancy.

The Center for Disease Control and Prevention estimates that 4% of women aged 15-44 years are using ADHD medication in the U.S., making these medications among most prescribed medications during pregnancy.

The researchers investigated whether the children in the study had developed neurological developmental disorders, including autism and ADHD, impaired vision or hearing, epilepsy, febrile seizures or growth retardation.

Previous animal studies and studies of illicit drug use in humans have shown that centrally stimulating drugs like methylphenidate and amphetamine, which are the most frequently used for ADHD, can pass to the fetus and have adverse effects. Therefore, it is important to know that no long-term adverse effects have been found so far in human children who were prenatally exposed to therapeutic doses of prescription stimulants is encouraging.

At the same time, the research team emphasizes that this study should be follows up by additional research, including inquiry into short-term outcomes, given that ADHD medication during pregnancy might be associated with other types of outcomes besides neurodevelopmental. (MSM/Newswise)

Hurry up! Join the Medical Internship 3.0 at MedBound!

Opioid Epidemic Reaches Beyond Health Impacts to Influence Politics

Sylvester Research Adds Cellular Therapy for Metastatic Melanoma (Skin Cancer)

Cancer Institute & Transplant & Cell Therapy Program in New Jersey Accredited

Study Finds Biomarkers for Psychiatric Symptoms in 22q Genetic Condition

Wonder Plants: Natural Mosquito Repellents for Your Home